TEL AVIV, Israel, September 6, 2011 /PRNewswire/ —
Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ:
EMITF) announced today, that Standard & Poor’s Maalot, has
decided to change the rating of all of the Company’s Series A
through Series G Notes and Series 1 Notes and of its subsidiary,
Plaza Centers N.V.’s Series A and Series B Notes, which are traded
on the Tel Aviv Stock Exchange, from an “ilA/Watch Negative” credit
rating, to an “ilBBB+/Negative” credit rating. Both the Company and
Plaza Centers N.V. were removed from Watch-list.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of
business: (i) Commercial and Entertainment Centers –
Initiation, construction and sale of shopping and entertainment
centers and other mixed-use real property projects, predominantly
in the retail sector, located in Central and Eastern Europe and in
India; (ii) U.S. Real Property – Investment in commercial
real property in the United States; (iii) Hotels – Hotel
operation and management, primarily in major European cities; (iv)
Medical Industries – (a) research and development,
production and marketing of magnetic resonance imaging guided
focused ultrasound treatment equipment and (b) development of stem
cell population expansion technologies and stem cell therapy
products for transplantation and regenerative medicine; (v)
Residential Projects – Initiation, construction and sale of
residential projects and other mixed-use real property projects,
predominately residential, located primarily in India and in
Eastern Europe; (vi) Fashion Apparel – Distribution and
marketing of fashion apparel and accessories in Israel; and (vii)
Other Activities – (a) venture capital investments and (b)
investments in hospitals and farm and dairy plants in India. We
have presently decided to suspend our investment activities in
hospitals and farm and dairy plants in India until
‘/>”/>
